JMJon C. Mills

Jon C. Mills

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jon C. Mills has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Age-Related Trajectories for Bone, Muscle, and Adipose Tissue in Healthy Adults: Impact of Osteosarcopenic Adiposity

    by Jasminka Z. Ilich, Jon Mills, Selma Cvijetic, Emily M. Barlow, Semira Galijasevic, Dario Boschiero, Jeffrey Harman

    Background/Objectives: Age-related changes in body composition (bone, muscle, and adipose tissue) are often assumed to follow linear, sex-specific patterns. Some evidence suggests that these trajectories are nonlinear, and their timing and dynamics remain poorly characterized. Osteosarcopenic adiposity/obesity (OSA), defined by the coexistence of osteopenia/osteoporosis, sarcopenia, and excess/redistributed adiposity, is recognized as a body composition disorder associated with multiple morbidities, but its impact on age-related body composition trajectories has not been fully explored. We aimed to delineate sex-specific, age-related trajectories of bone, muscle, fat mass, and intramuscular adipose tissue (IMAT), identify inflection points across adulthood, and compare patterns in individuals without and with OSA. Methods: Cross-sectional data from 9717 healthy Caucasian adults (aged 20–90 years) enrolled in a multicenter Italian study were analyzed. Body composition was measured using validated bioelectrical impedance analysis. LOESS regression was employed to identify age-related inflection points. Standard diagnostic criteria defined osteopenia/osteoporosis, sarcopenia, adiposity, and OSA. Results: Men exhibited earlier peaks and midlife stability in bone and muscle mass, followed by later decline. Women showed lower baseline values, multiple early-life inflection points, and sharper midlife downturns, particularly around menopause. Fat mass increased steadily in men but followed a multi-phasic pattern in women. IMAT rose progressively with age in both sexes. Adults with OSA, identified in participants even as young as 20 years, demonstrated destabilized trajectories, earlier downturns in bone and muscle, and more complex body fat and IMAT patterns. Conclusions: Distinct sex-specific patterns and mitigating effect of OSA on body composition trajectories were identified. Early detection of OSA may be crucial for preventing acceleration of musculoskeletal decline and rise in adiposity.

  • Culturally and linguistically adapting a transdiagnostic LGBTQ-affirming cognitive behavioral skills intervention for Vietnamese gay and bisexual men at risk for HIV: pre-adaptation qualitative interviews

    by Casey D. Xavier Hall, An Bao, Beren Crim Sabuncu, Liying Wang, Minh N. Luu, Jon Mills, Kathy Trang, Eugenia F. Millender, Brittany L. Lane, Doug H. Cheung, et al.

    In Việt Nam, men who have sex with men (MSM) have an estimated HIV prevalence of 13.3%. MSM in Việt Nam face significant stigma, which is a known factor increasing sexual risk behavior and HIV transmission. Interventions like Transdiagnostic LGBTQ-affirming Cognitive Behavioral Therapy (CBT) have been shown to reduce the impact of stigma, these interventions were developed in the context of the U.S. We aimed to identify cultural adaptations for LGBTQ-affirmative CBT skills in Vietnamese contexts. In-person interviews were conducted with MSM living in Ho Chi Minh City, Việt Nam (n = 17) in Vietnamese by native speakers, transcribed and translated to English. A team of four analysts used a Rapid Qualitative Analysis Method. Participants expressed a desire to learn emotional regulation skills, which aligns with existing LGBTQ-affirmative CBT skills content. They also suggested the inclusion of HIV prevention skills and most participants were in favor of group format. LGBTQ-affirmative CBT skills appear to be desired among MSM in Việt Nam to address the impact of identity-based stigma; however, content and format of the intervention should be adapted to meet their needs and maximize effectiveness. Future research should examine the impact of the adapted model on mental health and HIV risk.

  • Open Access

    The health for hearts united dissemination Trial: Implementation costs to reduce cardiovascular risk in African Americans

    by Jon C. Mills, Jeffrey Harman, Pauline Muturi, Christina Davis, Iris Young-Clark, Penny Ralston

  • The Impact of Cumulative Depression Along the HIV Care Continuum in Women Living With HIV During the Era of Universal Antiretroviral Treatment

    by Jon C. PhD Mills, Brian W. Pence, Andrew Edmonds, Adebola Adedimeji, Rebecca M. Schwartz, Seble Kassaye, Jennifer Cocohoba, Mardge H. Cohen, Gretchen Neigh, Margaret A. Fischl, et al.

    Background: Data are limited on cumulative impacts of depression on engagement in care and HIV outcomes in women living with HIV (WLWH) during the era of universal antiretroviral therapy (ART). Understanding the relationship of accumulated depression with HIV disease management may help identify benefits of interventions to reduce severity and duration of depressive episodes. Setting: A cohort of WLWH (N = 1491) from the Women's Interagency HIV Study at 9 sites across the US. Methods: This longitudinal observational cohort study (2013–2017) followed WLWH for a maximum of 9 semiannual visits. Depression was quantified as a time-updated measure of percent of days depressed (PDD) created from repeated assessments using the Center for Epidemiologic Studies Depression scale. Marginal structural Poisson regression models were used to estimate the effects of PDD on the risks of missing an HIV care appointment, <95% ART adherence, and virological failure (≥200 copies/mL). Results: The risk of missing an HIV care appointment [risk ratio (RR) = 1.16, 95% confidence interval = 0.93 to 1.45; risk difference (RD) = 0.01, −0.01 to 0.03], being <95% ART adherent (RR = 1.27, 1.06–1.52; RD = 0.04, −0.01 to 0.07), and virological failure (RR = 1.09, 1.01–1.18; RD = 0.01, −0.01 to 0.03) increased monotonically with increasing PDD (comparing those with 25 to those with 0 PDD). The total effect of PDD on virological failure was fully (%100) mediated by being <95% ART adherent. Conclusions: Time spent depressed increases the risk of virological failure through ART adherence, even in the era of universal ART regimes forgiving of imperfect adherence.


  • Open Access

    Association of Increased Chronicity of Depression With HIV Appointment Attendance, Treatment Failure, and Mortality Among HIV-Infected Adults in the United States

    by Brian W. Pence, Jon C. Mills, Angela M. Bengtson, Bradley N. Gaynes, Tiffany L. Breger, Robert L. Cook, Richard D. Moore, David J. Grelotti, Conall O’cLeirigh, Michael J. Mugavero

    Depression is one of the most common comorbidities affecting adults living with HIV, with prevalence estimates ranging from 20% to 40%.1-7 In addition to being a serious clinical concern, depression complicates the management of HIV: it has been linked to low adherence to antiretroviral therapy (ART),8 poor attendance at HIV primary care appointments,9 ART failure,10 accelerated clinical progression of HIV,11,12 and higher mortality rates.13-24


  • Cumulative Burden of Depression and All-Cause Mortality in Women Living With Human Immunodeficiency Virus

    by Jon C Mills, Brian W Pence, Jonathan V Todd, Angela M Bengtson, Tiffany L Breger, Andrew Edmonds, Robert L Cook, Adebola Adedimeji, Rebecca M Schwartz, Seble Kassaye, et al.

    Research linking depression to mortality among people living with human immunodeficiency virus (PLWH) has largely focused on binary “always vs never” characterizations of depression. However, depression is chronic and is likely to have cumulative effects on mortality over time. Quantifying depression as a cumulative exposure may provide a better indication of the clinical benefit of enhanced depression treatment protocols delivered in HIV care settings. Women living with HIV (WLWH), naive to antiretroviral therapy, from the Women’s Interagency HIV Study were followed from their first visit in or after 1998 for up to 10 semiannual visits (5 years). Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression (CES-D) scale. An area-under-the-curve approach was used to translate CES-D scores into a time-updated measure of cumulative days with depression (CDWD). We estimated the effect of CDWD on all-cause mortality using marginal structural Cox proportional hazards models. Overall, 818 women contributed 3292 woman-years over a median of 4.8 years of follow-up, during which the median (interquartile range) CDWD was 366 (97–853). Ninety-four women died during follow-up (2.9 deaths/100 woman-years). A dose–response relationship was observed between CDWD and mortality. Each additional 365 days spent with depression increased mortality risk by 72% (hazard ratio, 1.72; 95% confidence interval, 1.34–2.20). In this sample of WLWH, increased CDWD elevated mortality rates in a dose–response fashion. More frequent monitoring and enhanced depression treatment protocols designed to reduce CDWD may interrupt the accumulation of mortality risk among WLWH.


  • Open Access

    Key attributes of patient centered medical homes associated with patient activation of diabetes patients

    by Lori A. Bilello, Allyson Hall, Jeffrey Harman, Christopher Scuderi, Nipa Shah, Jon C. Mills, Shenae Samuels

    Approximately 24 million Americans are living with diabetes. Patient activation among individuals with diabetes is critical to successful diabetes management. The Patient Centered Medical Home (PCMH) model holds promise for increasing patient activation in managing their health. However, what is not well understood is the extent to which individual components of the PCMH model, such as the quality of physician-patient interactions and organizational features of care, contribute to patient activation. This study’s objective is to determine the relative importance of the PCMH constructs or domains to patient activation among individuals living with diabetes. This study is a cross-sectional analysis of 1253 primary care patients surveyed with type II diabetes. The dependent variable, patient activation, was assessed using the Patient Activation Measure (PAM). Independent variables included 7 PCMH domains- organizational access, integration of care, comprehensive knowledge, office staff helpfulness, communication, interpersonal treatment and trust. Ordered logistic regression was performed to determine whether each PCMH domain was independently associated with patient activation, followed by a final ordered logistic regression that included all the PCMH domains in a single adjusted model. Using the full adjusted model, the odds of patients reporting higher activation scores (PAM) were found to be significant in the domains that represented organizational access (OR 1.56, 95% CI 1.31–1.85) and comprehensive knowledge (OR 1.44, 95% CI 1.13–1.85). Many practices have struggled with the challenge to develop fully functional patient-centered medical homes. In an effort to become more patient-centered, this study aimed to address what factors activated diabetic patients to adhere to diabetes management plan. Understanding these factors can help identify PCMH attributes that practices can prioritize and improve upon to assist their patients in improving health outcomes. Study was not a clinical trial; therefore it was not registered.


  • Comparative effectiveness of dual vs. single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression

    by Jon C. Mills, Jeffrey S. Harman, Robert L. Cook, Nicole M. Marlow, Christopher A. Harle, R. Paul Duncan, Bradley N. Gaynes, Brian W. Pence

    Objective: Depression is highly prevalent among people living with HIV/AIDS (PLWHA) and has deleterious effects on HIV clinical outcomes. We examined changes in depression symptoms, viral suppression, and CD4+ T cells/μl among PLWHA diagnosed with depression who initiated antidepressant treatment during routine care, and compared the effectiveness of dual-action and single-action antidepressants for improving those outcomes. Design: Comparative effectiveness study of new user dual-action or single-action antidepressant treatment episodes occurring from 2004 to 2014 obtained from the Center for AIDS Research Network of Integrated Clinical Systems. Methods: We identified new user treatment episodes with no antidepressant use in the preceding 90 days. We completed intent-to-treat and per protocol evaluations for the main analysis. Primary outcomes, were viral suppression (HIV viral load + T cells/μl. In a secondary analysis, we used the Patient Health Questionnaire-9 (PHQ-9) to evaluate changes in depression symptoms and remission (PHQ +T cells/μl after initiating antidepressants (30, 48). Both the frequency of remission from depression and PHQ-9 scores improved after antidepressant initiation. Comparative effectiveness estimates were null in all models. Conclusion: Initiating antidepressant treatment was associated with improvements in depression, viral suppression, and CD4+ T cells/μl, highlighting the health benefits of treating depression in PLWHA. Dual and single-action antidepressants had comparable effectiveness.


  • Comparative effectiveness of dual-action versus single-action antidepressants for the treatment of depression in people living with HIV/AIDS

    by Jon C. Mills, Jeffrey S. Harman, Robert L. Cook, Nicole M. Marlow, Christopher A. Harle, R. Paul Duncan, Angela M. Bengtson, Brian W. Pence